2017
DOI: 10.1016/j.ejphar.2017.08.026
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of the mevalonate pathway by simvastatin interferes with mast cell degranulation by disrupting the interaction between Rab27a and double C2 alpha proteins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
14
0

Year Published

2018
2018
2025
2025

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 14 publications
(15 citation statements)
references
References 31 publications
1
14
0
Order By: Relevance
“…5) Previously, simvastatin was shown to disturbed Rab27a/Doc2a interaction. 6) Here we extend the study by Liu et al 4) to investigate whether zoledronate also disturbs Rab27a/Doc2a interaction during MC activation.…”
Section: Introductionsupporting
confidence: 58%
See 3 more Smart Citations
“…5) Previously, simvastatin was shown to disturbed Rab27a/Doc2a interaction. 6) Here we extend the study by Liu et al 4) to investigate whether zoledronate also disturbs Rab27a/Doc2a interaction during MC activation.…”
Section: Introductionsupporting
confidence: 58%
“…Simvastatin was previously shown to interfere Rab27a/ Doc2a interaction. 6) Zoledronate and simvastatin inhibition of HR are not affecting Ca 2+ mobilization and could be recovered by geranylgeraniol administration. 2,4,6) Zoledronate and simvastatin only inhibited histamine release after prolonged incubation (24 h).…”
Section: Discussionmentioning
confidence: 97%
See 2 more Smart Citations
“…Another strategy to attenuate inflammation and oxidative stress depend on using lipidlowering agents such as statins (Sahid et al, 2017;Rodrigues et al, 2019). Simvastatin, a member of the statin group, inhibits rate-limiting enzymes in cholesterol biosynthesis.…”
Section: Introductionmentioning
confidence: 99%